Cargando…
MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1
Breast cancer is the leading cause of cancer-related deaths in females worldwide. Triple-negative breast cancer (TNBC) accounts for 15% of all breast cancer cases and has a poorer prognosis than other subtypes. Moreover, the treatment for breast cancer, especially for TNBC, remains unsatisfactory. T...
Autores principales: | Wang, Yongxia, Zhang, Zheying, Wang, Jianqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5983929/ https://www.ncbi.nlm.nih.gov/pubmed/29693185 http://dx.doi.org/10.3892/or.2018.6385 |
Ejemplares similares
-
MicroRNA-384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB
por: Wang, Yongxia, et al.
Publicado: (2020) -
Cross-talk among AFAP1-AS1, ACVR1 and microRNA-384 regulates the stemness of pancreatic cancer cells and tumorigenicity in nude mice
por: Wu, Xu-Bo, et al.
Publicado: (2019) -
MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42
por: Gu, Gengshi, et al.
Publicado: (2018) -
MicroRNA-384 Inhibits the Growth and Invasion of Renal Cell Carcinoma Cells by Targeting Astrocyte Elevated Gene 1
por: Song, Haitao, et al.
Publicado: (2018) -
Suppression of microRNA-384 enhances autophagy of airway smooth muscle cells in asthmatic mouse
por: Cheng, Zhe, et al.
Publicado: (2017)